Cargando…
Immunotherapies and Metastatic Cancers: Understanding Utility and Predictivity of Human Immune Cell Engrafted Mice in Preclinical Drug Development
Metastases cause high mortality in several cancers and immunotherapies are expected to be effective in the prevention and treatment of metastatic disease. However, only a minority of patients benefit from immunotherapies. This creates a need for novel therapies that are efficacious regardless of the...
Autores principales: | Kähkönen, Tiina E., Halleen, Jussi M., Bernoulli, Jenni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352707/ https://www.ncbi.nlm.nih.gov/pubmed/32570871 http://dx.doi.org/10.3390/cancers12061615 |
Ejemplares similares
-
Osteoimmuno-Oncology: Therapeutic Opportunities for Targeting Immune Cells in Bone Metastasis
por: Kähkönen, Tiina E., et al.
Publicado: (2021) -
Insights into immuno-oncology drug development landscape with focus on bone metastasis
por: Kähkönen, Tiina E., et al.
Publicado: (2023) -
Human Immune System Increases Breast Cancer-Induced Osteoblastic Bone Growth in a Humanized Mouse Model without Affecting Normal Bone
por: Kähkönen, Tiina E., et al.
Publicado: (2019) -
Dovitinib dilactic acid reduces tumor growth and tumor-induced bone changes in an experimental breast cancer bone growth model
por: Kähkönen, Tiina E., et al.
Publicado: (2019) -
Critical evaluation of the subcutaneous engraftments of hormone naïve primary prostate cancer
por: Valta, Maija, et al.
Publicado: (2020)